Results 181 to 190 of about 119,784 (210)

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Lancet, The, 2010
Uri Lopatin, William D Bradford, Edward Gane   +2 more
exaly  

C1 inhibitor

2011
openaire   +1 more source

C1-inhibitor

2009
openaire   +1 more source

C1 Inhibitor Autoantibodies

1996
Alvin E. David, Marco Cicardi
openaire   +1 more source

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

C1-INHIBITOR PROTEIN

InPharma, 1980
openaire   +1 more source

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Lancet, The, 2013
Marina Cuchel, Dirk J Blom, A David Marais   +2 more
exaly  

C1 INHIBITOR AUTOANTIBODIES

2007
MARCO CICARDI, LORENZA C. ZINGALE
openaire   +1 more source

C1-inhibitor synthesis by monocytes of patients with C1-inhibitor deficiency

Biochemical Society Transactions, 1987
LINDA JONES, PENG-LEE YAP, ALBERT C. YEUNG-LAIWEH, KEITH WHALEY   +3 more
openaire   +1 more source

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Lancet, The, 2010
Michael Friedlander, Clare L Scott, Jeffrey N Weitzel   +2 more
exaly